DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Argus Research Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $540

Argus Research maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and raises the price target from $430 to $540.

Benzinga · 03/12/2020 12:15

Argus Research maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and raises the price target from $430 to $540.